US Stock MarketDetailed Quotes
VRPX Virpax Pharmaceuticals
- 0.4000
- +0.0991+32.93%
Close Dec 13 16:00 ET
- 0.3768
- -0.0232-5.80%
Post 20:01 ET
3.24MMarket Cap-0.06P/E (TTM)
0.4800High0.2860Low9.65MVolume0.3100Open0.3009Pre Close3.97MTurnover123.88%Turnover RatioLossP/E (Static)8.09MShares5.480052wk High-1.57P/B3.11MFloat Cap0.286052wk Low--Dividend TTM7.79MShs Float360.0000Historical High--Div YieldTTM64.47%Amplitude0.2860Historical Low0.4110Avg Price1Lot Size
Virpax Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -99.86%17.23K | -87.36%1.87M | -89.01%1.87M | -51.87%9.14M | -51.87%9.14M | -40.90%12.15M | -43.20%14.8M | -44.84%16.99M | -48.44%19M | -48.44%19M |
| -Cash and cash equivalents | -99.86%17.23K | -87.36%1.87M | -89.01%1.87M | -51.87%9.14M | -51.87%9.14M | -40.90%12.15M | -43.20%14.8M | -44.84%16.99M | -48.44%19M | -48.44%19M |
| Prepaid assets | -98.37%13.93K | -44.50%611.74K | 26.83%1.18M | -35.74%419.61K | -35.74%419.61K | 78.20%855.28K | 45.45%1.1M | -19.13%932.69K | 155.24%653.02K | 155.24%653.02K |
| Current deferred assets | --125.64K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 389.40%147.37K | 139.90%108.14K | -85.83%81.31K | 165.27%67.22K | 165.27%67.22K | -98.84%30.11K | -98.26%45.08K | -79.48%573.74K | -98.98%25.34K | -98.98%25.34K |
| Total current assets | -97.67%304.16K | -83.76%2.59M | -83.07%3.13M | -51.06%9.63M | -51.06%9.63M | -44.84%13.04M | -45.75%15.95M | -46.78%18.49M | -50.28%19.67M | -50.28%19.67M |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -97.67%304.16K | -83.76%2.59M | -83.07%3.13M | -51.06%9.63M | -51.06%9.63M | -44.84%13.04M | -45.75%15.95M | -46.78%18.49M | -50.28%19.67M | -50.28%19.67M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 190.06%96.28K | -0.87%75.4K | -70.66%13.28K | -50.97%18.46K | -50.97%18.46K | 131.77%33.19K | 169.35%76.06K | 335.06%45.25K | 89.73%37.64K | 89.73%37.64K |
| -Other payable | 190.06%96.28K | -0.87%75.4K | -70.66%13.28K | -50.97%18.46K | -50.97%18.46K | 131.77%33.19K | 275.82%76.06K | 335.06%45.25K | 89.73%37.64K | 89.73%37.64K |
| Current accrued expenses | 56.80%2.26M | 110.20%2.81M | 46.56%1.83M | 58.53%1.68M | 58.53%1.68M | -65.64%1.44M | -45.55%1.34M | -42.61%1.25M | -48.89%1.06M | -48.89%1.06M |
| Other current liabilities | ---- | 25.00%2.5M | 25.00%2.5M | 200.00%6M | 200.00%6M | --5M | --2M | --2M | --2M | --2M |
| Current liabilities | -63.94%2.36M | 47.67%5.39M | 31.86%4.34M | 148.63%7.69M | 148.63%7.69M | 55.25%6.53M | 46.85%3.65M | 50.64%3.29M | 48.23%3.09M | 48.23%3.09M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -63.94%2.36M | 47.67%5.39M | 31.86%4.34M | 148.63%7.69M | 148.63%7.69M | 55.25%6.53M | 46.85%3.65M | 50.64%3.29M | 48.23%3.09M | 48.23%3.09M |
| Shareholders'equity | ||||||||||
| Share capital | -58.12%49 | -76.07%28 | -89.74%12 | 0.00%12 | 0.00%12 | 0.00%117 | 0.00%117 | 0.00%117 | -89.74%12 | -89.74%12 |
| -common stock | -58.12%49 | -76.07%28 | -89.74%12 | 0.00%12 | 0.00%12 | 0.00%117 | 0.00%117 | 0.00%117 | -89.74%12 | -89.74%12 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -24.08%-68.22M | -35.17%-66.21M | -36.82%-62.76M | -34.25%-59.54M | -34.25%-59.54M | -32.91%-54.98M | -45.25%-48.99M | -64.78%-45.88M | -95.36%-44.35M | -95.36%-44.35M |
| Paid-in capital | 7.61%66.17M | 3.47%63.42M | 0.78%61.55M | 0.89%61.48M | 0.89%61.48M | 1.14%61.49M | 1.07%61.29M | 1.12%61.07M | 1.24%60.93M | 1.24%60.93M |
| Total stockholders'equity | -131.54%-2.05M | -122.71%-2.79M | -107.98%-1.21M | -88.33%1.93M | -88.33%1.93M | -66.51%6.51M | -54.29%12.3M | -53.32%15.2M | -55.77%16.58M | -55.77%16.58M |
| Total equity | -131.54%-2.05M | -122.71%-2.79M | -107.98%-1.21M | -88.33%1.93M | -88.33%1.93M | -66.51%6.51M | -54.29%12.3M | -53.32%15.2M | -55.77%16.58M | -55.77%16.58M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
